Showing results (771-780 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 1, 1993
Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressantsP L Delgado, H L Miller, R M Salomon, et al.Psychopharmacology Bulletin|January 1, 1989
Immune correlates of stress and depressionD L Evans, J Leserman, C A Pedersen, et al.Psychopharmacology Bulletin|January 1, 1989
Diagnostic criteria for dysthymic disorderA Frances, J Kocsis, D Marin, et al.Psychopharmacology Bulletin|January 1, 1989
Dopamine deficiency in self-injurious behaviorG R Breese, H E Criswell, G E Duncan, et al.Psychopharmacology Bulletin|January 1, 1989
Meal-related cholecystokinin secretion in eating and affective disordersT D Geracioti, M A Kling, J R Joseph-Vanderpool, et al.Psychopharmacology Bulletin|January 1, 1989
Open assessment of the safety and efficacy of thioridazine in the treatment of patients with borderline personality disorderM H Teicher, C A Glod, S T Aaronson, et al.Psychopharmacology Bulletin|September 23, 2017
Collaborative Care in Ambulatory Psychiatry: Content Analysis of Consultations to a Psychiatric PharmacistDorothy Gotlib, Jolene R Bostwick, Seema Calip, et al.Psychopharmacology Bulletin|August 26, 2017
Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male SubjectsRosa Luo, Haig Bozigian, Roland Jimenez, et al.Psychopharmacology Bulletin|August 26, 2017
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood DisorderRichard C Josiassen, John M Kane, Grace S Liang, et al.Psychopharmacology Bulletin|January 9, 2019
Induction of Psychosis by CyclobenzaprineJohan Y Cohen, Amélie GuilbaultPageof 128